How platelets work in older patients with atrial fibrillation
Part of Heart & circulation clinical trials.
This study looks at how platelets work in older patients with atrial fibrillation who are getting a Watchman procedure, which is a device to reduce stroke risk. It aims to understand platelet function and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have been diagnosed with atrial fibrillation.
- Are scheduled to have a Watchman procedure.
- Are not currently taking antiplatelet medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study tests how well anticoagulant medicines dissolve blood clots in the heart of people with atrial fibrillation. It may help doctors choose the best treatment to prevent strokes.
This trial compares which two medicines work best after a device closes off a part of the heart called the left atrial appendage. It may help reduce stroke risk while balancing bleeding risk after your procedure.
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.